Inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4): a patent review (2012-2015)
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4): a patent review (2012-2015)
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 26, Issue 8, Pages 917-932
Publisher
Informa UK Limited
Online
2016-06-17
DOI
10.1080/13543776.2016.1202926
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use
- (2016) Jing Sun et al. Science Signaling
- Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use
- (2016) Jing Sun et al. Science Signaling
- Discovery and hit-to-lead optimization of 2,6-diaminopyrimidine inhibitors of interleukin-1 receptor-associated kinase 4
- (2015) William T. McElroy et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Initial optimization and series evolution of diaminopyrimidine inhibitors of interleukin-1 receptor associated kinase 4
- (2015) W. Michael Seganish et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of potent, selective, and orally bioavailable inhibitors of interleukin-1 receptor-associate kinase-4
- (2015) Zhulun Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- PID in Disguise: Molecular Diagnosis of IRAK-4 Deficiency in an Adult Previously Misdiagnosed With Autosomal Dominant Hyper IgE Syndrome
- (2015) Glynis Frans et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Selective interleukin-1 receptor–associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy
- (2015) Priscilla N. Kelly et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A historical overview of protein kinases and their targeted small molecule inhibitors
- (2015) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation
- (2015) William T. McElroy et al. ACS Medicinal Chemistry Letters
- Discovery and Structure Enabled Synthesis of 2,6-Diaminopyrimidin-4-one IRAK4 Inhibitors
- (2015) W. Michael Seganish et al. ACS Medicinal Chemistry Letters
- Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4
- (2014) L. Nathan Tumey et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Interleukin 1/Toll-like Receptor-induced Autophosphorylation Activates Interleukin 1 Receptor-associated Kinase 4 and Controls Cytokine Induction in a Cell Type-specific Manner
- (2014) Leah Cushing et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Recent Advances in the Discovery of Small Molecule Inhibitors of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) as a Therapeutic Target for Inflammation and Oncology Disorders
- (2014) Divya Chaudhary et al. JOURNAL OF MEDICINAL CHEMISTRY
- Kinase Drug Discovery – What’s Next in the Field?
- (2013) Philip Cohen et al. ACS Chemical Biology
- TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
- (2013) Yu Liu et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Two Phases of Inflammatory Mediator Production Defined by the Study of IRAK2 and IRAK1 Knock-in Mice
- (2013) E. Pauls et al. JOURNAL OF IMMUNOLOGY
- The problem of choice: current biologic agents and future prospects in RA
- (2013) Ernest H. Choy et al. Nature Reviews Rheumatology
- IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+Th17 cells
- (2012) Margherita Coccia et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
- (2012) Roy Fleischmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis
- (2011) Yijun Carrier et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Immune Complex-Mediated Cell Activation from Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients Elaborate Different Requirements for IRAK1/4 Kinase Activity across Human Cell Types
- (2010) E. Y. Chiang et al. JOURNAL OF IMMUNOLOGY
- Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency
- (2010) Capucine Picard et al. MEDICINE
- Unknown
- (2010) Gianfranco Ferraccioli et al. MOLECULAR MEDICINE
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- Interleukin-1 receptor-associated kinase 4 links innate immunity to the pathogenesis of rheumatoid arthritis
- (2009) Leo A. B. Joosten et al. ARTHRITIS AND RHEUMATISM
- The critical role of kinase activity of interleukin-1 receptor-associated kinase 4 in animal models of joint inflammation
- (2009) Magdalena Koziczak-Holbro et al. ARTHRITIS AND RHEUMATISM
- IRAK-4 Inhibitors for Inflammation
- (2009) Zhulun Wang et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress
- (2009) Luke A. J. O'Neill IMMUNOLOGICAL REVIEWS
- IRAK4 Kinase Activity Is Required for Th17 Differentiation and Th17-Mediated Disease
- (2009) K. A. Staschke et al. JOURNAL OF IMMUNOLOGY
- Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
- (2009) L. van der Fits et al. JOURNAL OF IMMUNOLOGY
- The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells
- (2009) Kyung W. Song et al. MOLECULAR IMMUNOLOGY
- IRAK4 in TLR/IL-1R signaling: Possible clinical applications
- (2008) Xiaoxia Li EUROPEAN JOURNAL OF IMMUNOLOGY
- Signalling mechanisms for Toll-like receptor-activated neutrophil exocytosis: key roles for interleukin-1-receptor-associated kinase-4 and phosphatidylinositol 3-kinase but not Toll/IL-1 receptor (TIR) domain-containing adaptor inducing IFN-β (TRIF)
- (2008) Agnieszka A. Brzezinska et al. IMMUNOLOGY
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- Pyogenic Bacterial Infections in Humans with MyD88 Deficiency
- (2008) H. von Bernuth et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search